STTK - Shattuck Labs Announces Participation in Upcoming 6th Annual Evercore ISI HealthCONx Conference | Benzinga

AUSTIN, TX & DURHAM, NC, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ:STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease, today announced that company management will participate in the 6^th Annual Evercore ISI HealthCONx Conference being held November 28-30, 2023.

Presentation Details
Conference: 6^th Annual Evercore ISI HealthCONx Conference
Format: Fireside chat with covering analyst, Jonathan ...

Full story available on Benzinga.com